Decellularized Extracellular Matrix - Tissue Engineering and Regenerative Medicine Biomaterials Laboratory

The Healtech CDMO plantfrom undertakes the special project of "National 13th Five Year Key R&D Plan for Biomaterials Research and Development and Organ Repair Replacement", realizing the transformation of scientific and technological achievements in "Engineering preparation technology and product development of low immunogenicity collagen and silk fibroin protein", and further reserving various new generation mainstream medical materials such as hyaluronic acid, PLA, PLLA, pectin, PCL, peptides, polyethylene, PVA, polyurethane, polytetrafluoroethylene, microcrystalline calcium, chitosan, hydroxyapatite, humanized collagen, etc.

Healtech has established the core technology platform of decellularized extracellular matrix (AOBM) and silk fibroin (SFM), to provide the overall solution of tissue repair and organ reconstruction.Healtech provides technology upgrades and new project reservation services for manufacturing and sales enterprises, and now has established strategic cooperation relationship with many domestic and international pharmaceutical and medical device enterprises. Currently, The plantfrom has reserved more than 80 technical projects, applied for 37 national patents, obtained 12 national invention patent certificates, and 5 medical device registration certificates, continuously creating new value for the health industry.

Decellularized Extracellular Matrix Silk Fibroin

Platform

· The Decellularized Extracellular Matrix Platform has approximately 3,000 square meters of workshops with various purification levels that comply with GMP standards, including 100,000-class, 10,000-class, and localized 100-class workshops.
· The Decellularized Extracellular Matrix Platform can meet the production requirements of various products such as injections, patches, gels, creams, lyophilized powders, etc.
· The Decellularized Extracellular Matrix Platform is capable of supporting the research, development, and production of various biomaterial medical devices.

Technology Advantage

Highly Effective

Decellularized extracellular matrix is naturally biomimetic to provide an optimal microenvironment for cell growth.

The composition and structure of normal tissue decellularized extracellular matrix is retained after tissue decellularization, which can replace or repair damaged tissues.

Decellularized extracellular matrix is rich in cytokines and functional polypeptides, with the ability of tissue microenvironment regulation and Promoting Vascularization.

It Accelerates the healing cycle of damaged tissues.

Consult Now

High Safety

Low immunogenicity: More complete degreasing and decellularization.

Without disrupting the composition and structure of the extracellular matrix

Degradation products are 100% absorbed and metabolized by the human body.

Consult Now

Application

Applied to the Repair of Various Tissues and Organs: skin, organs, bone, cartilage, tendon, etc.

All Kinds of Surgical Patches: dura mater, hernia, pelvic floor repair, etc.

Excellent Tissue Filler Materials: scar treatment, facial plastic surgery and other medical aesthetic fields.

Adjuvant Treatment for Cell Therapy: fat cells, stem cells and other injectable carriers to improve the efficiency of cell therapy.

Adjust the Form According to Indications: biofilm, sponge, gel, granule, etc.

Consult Now

Online Consultation

Telephone consultation